GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (LTS:0QK8) » Definitions » Debt-to-Equity

Baxter International (LTS:0QK8) Debt-to-Equity : 1.68 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Baxter International Debt-to-Equity?

Baxter International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $2,498 Mil. Baxter International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $10,696 Mil. Baxter International's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $7,872 Mil. Baxter International's debt to equity for the quarter that ended in Sep. 2024 was 1.68.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Baxter International's Debt-to-Equity or its related term are showing as below:

LTS:0QK8' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.32   Med: 0.78   Max: 3.05
Current: 1.68

During the past 13 years, the highest Debt-to-Equity Ratio of Baxter International was 3.05. The lowest was 0.32. And the median was 0.78.

LTS:0QK8's Debt-to-Equity is ranked worse than
92.76% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs LTS:0QK8: 1.68

Baxter International Debt-to-Equity Historical Data

The historical data trend for Baxter International's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baxter International Debt-to-Equity Chart

Baxter International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.78 2.02 2.95 1.71

Baxter International Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.09 1.71 1.73 1.75 1.68

Competitive Comparison of Baxter International's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Baxter International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baxter International's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Baxter International's Debt-to-Equity falls into.



Baxter International Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Baxter International's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Baxter International's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baxter International  (LTS:0QK8) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Baxter International Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Baxter International's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Baxter International Business Description

Address
One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.

Baxter International Headlines

No Headlines